Terms: = Head and neck cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
5 results:
1. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
2. head and neck cancer treatment outcome priorities: A multi-perspective concept mapping study.
Alolayan WR; Rieger JM; Yoon MN
PLoS One; 2023; 18(11):e0294712. PubMed ID: 38033014
[TBL] [Abstract] [Full Text] [Related]
3. Margetuximab: First Approval.
Markham A
Drugs; 2021 Apr; 81(5):599-604. PubMed ID: 33761116
[TBL] [Abstract] [Full Text] [Related]
4. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution.
Fakhrian K; Ordu AD; Lordick F; Theisen J; Haller B; Omrčen T; Molls M; Nieder C; Geinitz H
Strahlenther Onkol; 2014 Nov; 190(12):1133-40. PubMed ID: 25015426
[TBL] [Abstract] [Full Text] [Related]
5. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
[TBL] [Abstract] [Full Text] [Related]
